Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2014; 20(15): 4370-4376
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4370
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4370
Figure 1 Progression-free survival and overall survival according to BRAF or KRAS mutation status.
A: PFS was not significantly different by the BRAF mutation status (P = 0.135); B: OS was significantly poorer in the BRAF mutant group than in the BRAF wild-type group (P = 0.041); PFS (C) and OS (D) were not significantly different by the KRAS mutation status (P = 0.954 and P = 0.536, respectively). PFS: Progression-free survival; OS: Overall survival.
-
Citation: Kim B, Park SJ, Cheon JH, Kim TI, Kim WH, Hong SP. Clinical meaning of
BRAF mutation in Korean patients with advanced colorectal cancer. World J Gastroenterol 2014; 20(15): 4370-4376 - URL: https://www.wjgnet.com/1007-9327/full/v20/i15/4370.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i15.4370